PEP12 Antibody

What is PEP12/SYP21 and why is it important for cellular research?

PEP12 (SYP21 in plants) is a SNARE protein that functions in the prevacuolar compartment (PVC) and mediates vesicle trafficking between the Golgi apparatus and vacuole. In Arabidopsis, PEP12/SYP21 was isolated through complementation of the yeast Δpep12 mutant and is expressed across all plant tissues . It belongs to the SYP2 (syntaxin of plants) group along with SYP22, and both serve essential non-redundant functions in vacuolar transport, as demonstrated by the lethal phenotypes resulting from gene disruption . In fungi like Candida albicans, PEP12 has been shown to be crucial for biofilm integrity and in vivo virulence . The importance of PEP12 in these fundamental cellular processes makes it a valuable target for studying membrane trafficking, vacuolar transport, and related cellular pathways.

What methods are most effective for detecting PEP12 using antibodies?

For effective detection of PEP12 using antibodies, researchers should consider:

• Western blotting: Affinity-purified antibodies against PEP12/SYP21 have shown good results in western blot applications, typically detecting bands of the expected size .

• Immunolocalization: In situ immunolocalization has been successful with affinity-purified antibodies against PEP12/SYP21, allowing visualization of subcellular localization patterns .

• Sample preparation: For optimum results, samples should be prepared carefully, considering that PEP12 is a membrane protein. Membrane fractionation before immunoblotting can improve detection sensitivity.

• Antibody purification: Generic purification methods (Caprylic acid precipitation, Protein A/G purification) may not improve detection rates significantly, but affinity purification with purified recombinant protein has shown substantial improvements in detection capability .

Validation against mutant backgrounds is essential to confirm antibody specificity, as demonstrated in several studies with plant SYP21 antibodies .

How should I validate a new PEP12 antibody for experimental use?

To properly validate a PEP12 antibody:

• Dot blot analysis: Initially test the antibody against the recombinant protein or peptide used for immunization. High-quality antibodies should detect target proteins in the picogram range .

• Western blot validation:

  • Test against wild-type samples to confirm the expected band size

  • Test against pep12 mutant/knockout samples as a negative control

  • Analyze multiple tissue types or conditions where PEP12 is differentially expressed

• Immunolocalization validation:

  • Compare localization patterns in wild-type versus mutant tissues

  • Co-localization with known PVC markers to confirm correct subcellular targeting

  • Absence of signal in pep12 mutant backgrounds (as shown for SYP21 in Arabidopsis)

• Cross-reactivity tests: Determine specificity against related SNARE proteins, especially other syntaxins like SYP22 in plants.

As noted in the CPIB antibody project, antibodies validated against their respective mutant backgrounds for cross-reactivity typically show no detectable signal in mutants, confirming their specificity .

What fixation and preparation methods are optimal for immunolocalization with PEP12 antibodies?

For optimal immunolocalization with PEP12 antibodies:

• Fixation protocols:

  • Paraformaldehyde fixation (3-4%) for 15-30 minutes at room temperature preserves antigenicity while maintaining structure

  • Avoid over-fixation which can mask epitopes

  • For some applications, a combination of paraformaldehyde and glutaraldehyde (0.1-0.5%) may better preserve membrane structures

• Sample preparation:

  • For plant tissues: cell wall digestion may be necessary for antibody penetration

  • For fungal cells: cell wall digestion using zymolyase or similar enzymes is critical

  • For cultured cells: gentle permeabilization with 0.1% Triton X-100 after fixation

• Blocking conditions:

  • 2-5% BSA or normal serum in PBS

  • Include 0.1% saponin or 0.1% Triton X-100 for membrane permeabilization

  • Block for at least 1 hour at room temperature

• Antibody dilutions and incubations:

  • Determine optimal primary antibody dilutions empirically (typically 1:100 to 1:1000)

  • Incubate overnight at 4°C for best results

  • Include proper washing steps (4-5 times) between primary and secondary antibody incubations

The successful detection of subcellular markers using similar approaches suggests these methods would be effective for PEP12 immunolocalization .

How can PEP12 antibodies be used to study membrane trafficking dynamics?

PEP12 antibodies can be powerful tools for studying membrane trafficking dynamics through several approaches:

• Pulse-chase immunoprecipitation:

  • Label cells with biotin or radioactive amino acids

  • Chase with non-labeled medium at various time points

  • Immunoprecipitate with PEP12 antibodies to track protein associations over time

  • Analyze co-precipitating proteins to identify transient trafficking components

• Co-immunoprecipitation studies:

  • Use PEP12 antibodies to pull down protein complexes

  • Identify interacting partners by mass spectrometry

  • This approach has revealed that SYP21 immunoprecipitates with the Qb-SNARE VTI11 and Qc-SNARE SYP51, supporting their role in a SNARE complex involved in Golgi-to-PVC trafficking

• Live cell imaging combined with immunolocalization:

  • Track GFP-tagged cargo proteins in live cells

  • Fix cells at defined time points

  • Perform immunolocalization with PEP12 antibodies

  • Analyze co-localization to determine transit through the PVC

• Organelle isolation:

  • Use PEP12 antibodies for immunomagnetic isolation of PVC compartments

  • Analyze protein and lipid composition at different stages of trafficking

  • Combine with proteomics to identify novel trafficking components

• Effects of trafficking inhibitors:

  • Treat cells with drugs affecting different trafficking steps

  • Analyze changes in PEP12 localization and associated proteins

  • This approach can reveal dependency relationships in trafficking pathways

Studies using PEP12/SYP21 antibodies have shown that overexpression of this syntaxin inhibits export from the PVC without affecting the Golgi complex, providing insights into the directionality of membrane trafficking .

What are the critical differences between using peptide-derived versus recombinant protein-derived PEP12 antibodies?

The choice between peptide-derived and recombinant protein-derived PEP12 antibodies significantly impacts experimental outcomes:

Evidence from antibody development projects indicates that recombinant protein-derived antibodies performed better in both immunolocalization and western blot applications . A significant improvement in detection rates was observed following affinity purification with the purified recombinant protein, with 55% of such antibodies successfully detecting signals either by immunolocalization (22 out of 38) or western blotting (20 out of 32) .

For PEP12/SYP21, using recombinant protein-derived antibodies that recognize the cytosolic domain would likely provide better results for most applications, especially when studying protein interactions and localization in intact cellular compartments.

What approaches can resolve weak or non-specific signals when using PEP12 antibodies?

When troubleshooting weak or non-specific signals with PEP12 antibodies:

• Antibody purification strategies:

  • Generic purification methods (Caprylic acid precipitation, Protein A/G) may not significantly improve detection

  • Affinity purification against the target protein substantially improves signal quality and specificity

  • Consider preparing fresh antibody aliquots to avoid freeze-thaw cycles

• Signal amplification methods:

  • Tyramide signal amplification can enhance weak signals

  • Use of high-sensitivity detection systems for western blotting

  • For immunofluorescence, consider secondary antibodies with brighter fluorophores or use biotin-streptavidin systems

• Background reduction strategies:

  • Increase blocking stringency (5% BSA or milk, longer blocking times)

  • Add 0.1-0.5% non-ionic detergent to reduce non-specific membrane binding

  • Include competing peptides from related proteins to improve specificity

  • Pre-adsorb antibodies against tissues from knockout/mutant organisms

• Sample optimization:

  • For membrane proteins like PEP12, ensure proper solubilization

  • Optimize detergent concentration for western blotting

  • For immunolocalization, test different fixation and permeabilization protocols

• Validation controls:

  • Always include mutant/knockout samples as negative controls

  • Use overexpression systems as positive controls

  • Consider epitope-tagged versions of PEP12 for dual detection strategies

Research has shown that affinity purification with purified recombinant protein significantly improved detection rates for many antibodies, including those targeting membrane trafficking proteins .

How can PEP12 antibodies facilitate studies on PVC-mediated protein sorting and trafficking?

PEP12 antibodies enable sophisticated analyses of PVC-mediated protein sorting through:

• Cargo trafficking analysis:

  • Immunoprecipitate PEP12-containing compartments at different time points

  • Analyze the flux of cargo proteins through these compartments

  • Studies have shown that PEP12/SYP21 overexpression inhibits export from the PVC, causing accumulation of soluble and membrane cargo and the vacuolar sorting receptor BP80

• Receptor recycling studies:

  • Track the localization and movement of vacuolar sorting receptors like BP80

  • PEP12/SYP21 overexpression affects both anterograde membrane flow to the vacuole and the recycling route of BP80 to the Golgi

  • Use co-immunoprecipitation with PEP12 antibodies to identify novel components of these pathways

• Organelle dynamics visualization:

  • Use PEP12 antibodies to track PVC clustering and fusion events

  • Research has documented that PVC bodies can move together and possibly fuse, forming enlarged compartments

  • Combine with live imaging of fluorescently-tagged proteins

• Protein sorting mechanism studies:

  • Determine how cargo proteins are recognized and sorted in the PVC

  • Analyze the effect of mutations in sorting signals on co-localization with PEP12

  • Investigate how disruption of PEP12 function affects sorting to different destinations

• Pathway dissection experiments:

  • Use PEP12 antibodies to determine whether specific cargo proteins transit through the PVC

  • Compare trafficking in wild-type and PEP12-mutant backgrounds

  • Research has shown that while PEP12/SYP21 overexpression inhibits PVC export, it does not affect Golgi-mediated transport toward the plasma membrane

These approaches have revealed that PEP12/SYP21 plays a specific role in export from the PVC without compromising the secretory branch of the endomembrane system .

What are the critical controls needed when using PEP12 antibodies in co-localization studies?

For rigorous co-localization studies using PEP12 antibodies:

• Negative controls:

  • pep12/syp21 mutant tissues to confirm antibody specificity

  • Primary antibody omission to assess secondary antibody non-specific binding

  • Isotype controls to evaluate non-specific binding of primary antibodies

• Positive controls:

  • Co-staining with established PVC markers

  • Transfection/transformation with fluorescently-tagged PEP12/SYP21

  • Known PEP12-interacting proteins (e.g., VTI11, SYP51 in plants)

• Methodological controls:

  • Single-color controls to establish proper filter settings and eliminate bleed-through

  • Sequential scanning for confocal microscopy to prevent cross-channel interference

  • Careful selection of fluorophore pairs to minimize spectral overlap

• Analytical validation:

  • Quantitative co-localization analysis using Pearson's or Mander's coefficients

  • Random region analysis to establish baseline co-localization values

  • Z-stack analysis to ensure co-localization is not due to superimposition

• Biological validation:

  • Treatment with drugs that affect PVC formation/dynamics

  • Examination of co-localization under conditions that alter trafficking

  • Comparison across different cell types or tissues

Research has validated several subcellular marker antibodies, including those for BiP (endoplasmic reticulum), γ-COP (Golgi), PM-ATPase (plasma membrane), and GNOM (endosome), which can serve as important controls in co-localization studies with PEP12/SYP21 .

How do PEP12 antibodies perform across different species and model organisms?

PEP12 antibodies show variable cross-reactivity and performance across species:

C. albicans PEP12 homolog was identified by searching the Candida Genome Database and CandidaDB , while Arabidopsis PEP12/SYP21 was isolated by complementation of the yeast Δpep12 mutant . This suggests evolutionary conservation that might allow some cross-reactivity, but species-specific antibodies are generally recommended for optimal results.

In Arabidopsis, antibodies against AtSYP21 (PEP12) have been successfully used for both western blotting and immunolocalization with proper validation against mutant backgrounds .

What protocols are available for using PEP12 antibodies in fungal research models?

For fungal research models like Candida and Saccharomyces:

• Protein extraction and western blotting:

  • Cell wall digestion: Treat cells with zymolyase or lyticase in osmotically stabilized buffer

  • Membrane protein extraction: Use buffer containing 1% Triton X-100 or NP-40

  • Sample preparation: Include protease inhibitors and keep samples cold

  • Gel running conditions: 12-15% SDS-PAGE gels are typically optimal

  • Transfer: Semi-dry or wet transfer with 0.05% SDS in transfer buffer

  • Blocking: 5% non-fat milk or BSA in TBST (2-3 hours)

  • Primary antibody: Incubate overnight at 4°C (1:500-1:2000 dilution)

• Immunolocalization in fungi:

  • Fixation: 4% paraformaldehyde for 30 minutes at room temperature

  • Cell wall digestion: 100μg/ml zymolyase in sorbitol buffer for 30 minutes

  • Permeabilization: 0.1% Triton X-100 for 15 minutes

  • Blocking: 2% BSA, 0.1% Tween-20 in PBS (1 hour)

  • Primary antibody: Incubate overnight at 4°C

  • Secondary antibody: Fluorescent conjugates (1:500-1:1000) for 1-2 hours

  • Mounting: Anti-fade medium with DAPI for nuclear visualization

• Validation strategies in fungal systems:

  • Compare wild-type vs. pep12Δ null mutant strains

  • The C. albicans pep12Δ null mutant can be generated by disrupting both chromosomal alleles using PCR-based gene disruption strategy

  • Verify homologous integration by allele-specific PCR and Southern blotting

  • Confirm correct strain construction by Southern blotting using digoxigenin-labeled probes

Research with C. albicans has demonstrated that PEP12 plays a key role in biofilm integrity and virulence , making PEP12 antibodies valuable tools for studying these processes.

Can PEP12 antibodies be used effectively for subcellular fractionation experiments?

PEP12 antibodies can be valuable tools for subcellular fractionation:

• Immunomagnetic isolation of PVC:

  • Homogenize tissue/cells in isotonic buffer

  • Perform differential centrifugation to obtain a microsomal fraction

  • Incubate with PEP12 antibodies conjugated to magnetic beads

  • Isolate PEP12-positive compartments using a magnetic separator

  • Validate purity using markers for other compartments

• Density gradient fractionation validation:

  • Fractionate cell homogenates on sucrose or Percoll gradients

  • Collect fractions and analyze by western blotting

  • Use PEP12 antibodies to identify PVC-containing fractions

  • Compare with markers for other compartments (e.g., BiP for ER, γ-COP for Golgi)

  • Analyze co-fractionation with cargo proteins

• Free-flow electrophoresis applications:

  • Separate organelles based on surface charge

  • Identify PVC fractions using PEP12 antibodies

  • Analyze lipid and protein composition of isolated fractions

• Proteomic analysis of isolated compartments:

  • Immunoisolate PEP12-containing compartments

  • Perform mass spectrometry to identify associated proteins

  • Compare protein profiles under different conditions

• Verification strategies:

  • Use phospholipase D treatment to verify the nature of membrane components

  • Employ phase partitioning with Triton X-114 to separate hydrophobic components

  • Confirm identity of isolated compartments with multiple markers

These approaches allow researchers to isolate and characterize PVC compartments, enabling detailed analysis of their composition and function in various cellular processes.

What are common pitfalls when using PEP12 antibodies and how can they be addressed?

Common pitfalls and solutions when working with PEP12 antibodies include:

Research has shown that generic purification methods often don't improve detection rates for antibodies, while affinity purification with purified recombinant protein significantly enhances performance .

What are the optimal storage and handling conditions for maintaining PEP12 antibody activity?

For optimal maintenance of PEP12 antibody activity:

• Storage conditions:

  • Store concentrated antibody stocks (>1mg/ml) at -80°C in small aliquots

  • Add glycerol (final concentration 30-50%) for freeze protection

  • Working dilutions can be stored at 4°C with 0.02% sodium azide for 1-2 weeks

  • Avoid repeated freeze-thaw cycles which can cause antibody denaturation

  • Store lyophilized antibodies at -20°C with desiccant

• Handling guidelines:

  • Always keep antibodies on ice during experiments

  • Centrifuge briefly before opening tubes to collect condensation

  • Use clean, low-protein binding tubes for dilutions

  • Prepare fresh working dilutions for critical experiments

  • Filter antibody solutions if precipitation occurs

• Stabilization additives:

  • BSA (0.1-1%) can stabilize dilute antibody solutions

  • Glycerol (25-50%) prevents freeze damage

  • Sodium azide (0.02-0.05%) prevents microbial growth

  • Avoid thiols and reducing agents which can damage antibody structure

• Quality control measures:

  • Test antibody activity periodically against positive controls

  • Monitor for changes in background or signal intensity

  • Keep records of antibody performance over time

  • Consider preparing new aliquots if performance degrades

• Shipping and temporary storage:

  • Ship on dry ice for long distances

  • For short-term transport (<24h), ship with ice packs

  • Upon receipt, aliquot and freeze immediately

Proper storage and handling are essential for maintaining antibody activity and experimental reproducibility, particularly for membrane protein targets like PEP12.

How should researchers design experiments to study PEP12 dynamics during cellular stress?

To effectively study PEP12 dynamics during cellular stress:

Research has shown that PEP12/SYP21 plays key roles in membrane trafficking , and stress conditions often alter these pathways, making this an important area for investigation.

What methods can verify antibody specificity when studying PEP12 in novel experimental systems?

When verifying PEP12 antibody specificity in novel systems:

• Genetic validation approaches:

  • Test antibody against knockout/knockdown cells or tissues

  • Use CRISPR-Cas9 to generate targeted mutations in PEP12

  • Compare with overexpression systems

  • CPIB antibody project validated several antibodies against their respective mutant backgrounds, showing no detectable signals in mutants

• Biochemical validation methods:

  • Perform peptide competition assays with the immunizing antigen

  • Pre-adsorb antibody against recombinant PEP12 protein

  • Compare reactivity with related proteins (e.g., other syntaxins)

  • Immunoprecipitation followed by mass spectrometry identification

• Heterologous expression systems:

  • Express tagged versions of PEP12 in easily transfectable cell lines

  • Perform dual labeling with tag-specific and PEP12 antibodies

  • Create chimeric proteins to map the epitope region

  • Test cross-reactivity with PEP12 homologs from other species

• Orthogonal detection methods:

  • Compare results from multiple antibodies targeting different epitopes

  • Correlate protein detection with mRNA expression (RT-PCR, RNA-seq)

  • Use proximity ligation assays to confirm interactions with known partners

  • Verify subcellular localization using cell fractionation and western blotting

• Controls for specific applications:

  • For immunohistochemistry: Include absorption controls with specific and non-specific peptides

  • For flow cytometry: Use isotype controls and fluorescence-minus-one controls

  • For western blotting: Include molecular weight markers and positive control samples

The CPIB antibody project demonstrated that affinity purification with purified recombinant protein significantly improved antibody specificity and performance in detecting target proteins .

How might advances in antibody technology enhance PEP12 research in the coming years?

Emerging antibody technologies will significantly advance PEP12 research:

• Single-domain antibodies (nanobodies):

  • Smaller size allows access to restricted epitopes in native membrane proteins

  • Can penetrate dense structures like biofilms where PEP12 functions are critical

  • Potential for intracellular expression to track PEP12 in living cells

  • Enhanced stability for challenging experimental conditions

• Super-resolution microscopy-compatible antibodies:

  • Site-specific labeling with small organic fluorophores

  • Reduction of linkage error through direct conjugation

  • Multi-color imaging to track PEP12 dynamics at nanometer resolution

  • Quantitative analysis of PEP12 clustering and interaction domains

• Genetically encoded antibody-based sensors:

  • FRET-based sensors to detect PEP12 conformational changes during SNARE complex formation

  • Split fluorescent protein complementation to visualize PEP12 interactions in real-time

  • Ratiometric sensors to measure local pH or lipid environments of PEP12-containing compartments

  • Optogenetic control of antibody binding for temporal manipulation

• High-throughput screening applications:

  • Antibody arrays to profile PEP12 interactions under various conditions

  • Single-cell analysis of PEP12 dynamics across populations

  • Automated image analysis for detecting subtle phenotypes in large datasets

  • Drug screening for compounds affecting PEP12-mediated trafficking

• Antibody engineering for therapeutic applications:

  • Targeting fungal PEP12 for anti-Candida therapeutics, given its role in biofilm formation and virulence

  • Developing antibody-drug conjugates for selective delivery to PEP12-expressing compartments

  • Engineering cell-penetrating antibodies to modulate intracellular trafficking pathways

These technological advances promise to reveal new insights into the fundamental roles of PEP12 in membrane trafficking, cellular homeostasis, and pathogenesis.

What are the most promising research directions for understanding PEP12 function using antibody-based approaches?

Promising research directions using PEP12 antibodies include:

• Temporal dynamics of trafficking pathways:

  • Pulse-chase studies with synchronized cellular events

  • Investigation of how PEP12-mediated pathways adapt to changing conditions

  • Analysis of PEP12-containing compartment maturation over time

  • Research has shown that PEP12/SYP21 overexpression inhibits export from the PVC , suggesting temporal regulation is critical

• Protein-lipid interactions:

  • Immunoisolation of PEP12-containing membranes for lipidomic analysis

  • Study of how lipid composition affects PEP12 function and localization

  • Investigation of ubiquitinated phospholipids in PEP12-positive compartments

  • Correlation between membrane composition and trafficking efficiency

• Structural biology approaches:

  • Use of conformation-specific antibodies to trap specific states of PEP12

  • Cryo-electron microscopy of immunopurified PEP12-containing membranes

  • Single-particle analysis of PEP12 in SNARE complexes

  • Mapping of functional domains through epitope-specific antibodies

• Disease models and pathogenesis:

  • Investigation of PEP12's role in fungal pathogenesis and biofilm formation

  • Studies of trafficking defects in neurodegenerative and storage diseases

  • Analysis of how pathogens may target PEP12-dependent pathways

  • Development of intervention strategies based on PEP12 function

• Systems biology integration:

  • Quantitative proteomics of PEP12-immunopurified compartments under various conditions

  • Network analysis of PEP12 interactions in health and disease

  • Computational modeling of how PEP12-mediated trafficking affects cellular homeostasis

  • Multi-omics approaches to understand PEP12 regulation at multiple levels

These research directions will provide deeper insights into how PEP12 contributes to fundamental cellular processes and potential applications in biotechnology and medicine.

What are the key recommendations for researchers beginning work with PEP12 antibodies?

For researchers starting work with PEP12 antibodies:

• Antibody selection and validation:

  • Choose antibodies raised against recombinant proteins rather than peptides when possible

  • Validate antibody specificity using genetic approaches (knockout/mutant controls)

  • Verify performance in your specific experimental system before conducting major studies

  • Consider using established antibodies from resources like the CPIB antibody project

• Experimental design considerations:

  • Include appropriate positive and negative controls in every experiment

  • Design time courses appropriate for the trafficking processes being studied

  • Use multiple detection methods to confirm key findings

  • Consider species-specific differences in PEP12 structure and function

• Technical optimizations:

  • For membrane proteins like PEP12, optimize extraction and sample preparation

  • Perform antibody titration experiments to determine optimal concentrations

  • Consider affinity purification to improve antibody specificity

  • Store antibodies as recommended to maintain activity

• Complementary approaches:

  • Combine antibody-based detection with genetic tools (GFP fusions, CRISPR)

  • Use multiple markers to establish proper compartment identity

  • Correlate protein detection with functional assays

  • Consider co-localization with interacting partners like VTI11 and SYP51

Following these recommendations will help ensure reliable and reproducible results when studying PEP12 function in various biological systems.

How can researchers integrate PEP12 antibody studies with other techniques for comprehensive analysis?

For comprehensive analysis, integrate PEP12 antibody studies with:

• Multi-omics integration:

  • Combine PEP12 immunoprecipitation with mass spectrometry proteomics

  • Correlate PEP12 localization changes with transcriptomic alterations

  • Integrate lipidomic analysis of PEP12-positive compartments

  • Link genetic variations to functional changes in PEP12-mediated trafficking

• Advanced imaging approaches:

  • Combine traditional immunofluorescence with super-resolution techniques

  • Use correlative light and electron microscopy to link PEP12 localization with ultrastructure

  • Implement live cell imaging followed by fixed-cell antibody detection

  • Apply quantitative image analysis for objective assessment of localization patterns

• Functional genomics integration:

  • Use CRISPR screens to identify novel regulators of PEP12 function

  • Correlate phenotypic changes from genetic screens with PEP12 localization

  • Implement synthetic genetic array analysis to identify genetic interactions

  • Apply optogenetic tools to manipulate trafficking pathways temporally

• Biochemical and biophysical methods:

  • Combine immunoprecipitation with in vitro reconstitution assays

  • Use surface plasmon resonance to measure interaction kinetics of purified components

  • Apply structural techniques (X-ray crystallography, cryo-EM) to PEP12 complexes

  • Implement membrane biophysics approaches to study PEP12 in artificial membranes

• Computational biology approaches:

  • Develop predictive models of trafficking based on experimental data

  • Use machine learning for image analysis of PEP12 localization patterns

  • Implement systems biology frameworks to integrate multiple data types

  • Apply network analysis to position PEP12 within larger cellular pathways

This integrated approach provides a comprehensive understanding of PEP12 function beyond what any single technique can reveal.

What quality control measures are essential for publishing research using PEP12 antibodies?

Essential quality control measures for publication-quality research with PEP12 antibodies:

• Antibody validation documentation:

  • Provide complete details about the antibody source, catalog number, and lot

  • Document validation experiments (western blot, immunoprecipitation, immunofluorescence)

  • Include images of controls (knockout/mutant backgrounds)

  • Deposit validation data in public repositories when possible

• Experimental reproducibility measures:

  • Report number of independent biological replicates

  • Include statistical analysis of quantitative data

  • Clearly state sample sizes and exclusion criteria

  • Document all experimental conditions in detail for reproducibility

• Image acquisition and processing standards:

  • Provide details of microscope settings, exposure times, and processing parameters

  • Use consistent acquisition parameters across comparative samples

  • Apply minimal image processing and document all steps

  • Include scale bars and indicate when images are representative

• Controls for specific techniques:

  • Western blot: Show full blots with molecular weight markers

  • Immunoprecipitation: Include isotype controls and input samples

  • Immunofluorescence: Show single-channel images alongside merges

  • Co-localization: Include appropriate statistical measures and randomized controls

• Method reporting requirements:

  • Provide detailed protocols for sample preparation

  • Document antibody dilutions and incubation conditions

  • Include all buffer compositions

  • Describe equipment and software used for analysis